Benitec Biopharma Inc (BNTC)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 0 0 0 0
Cost of Revenue 0 0 0 91,000
Gross Profit 0 0 0 -91,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 4,208,000 3,538,000 2,206,000 2,036,000
Operating Expenses 10,188,000 8,610,000 5,791,000 5,457,000
Operating Income -10,188,000 -8,610,000 -5,791,000 -5,548,000
Interest Expense 823,000 0 0 0
Income Before Tax -9,354,000 -7,357,000 -5,059,000 -4,720,000
Income Tax Expense 0 0 0 0
Net Income -9,354,000 -7,357,000 -5,059,000 -4,720,000
Per Share
EPS -0.24 -0.33 -0.48 -0.58
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 0 216,000 75,000 73,000 59,000
Cost of Revenue 396,000 108,000 381,000 9,000 123,000
Gross Profit -396,000 108,000 -306,000 64,000 -64,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 23,433,000 6,989,000 6,382,000 6,646,000 6,512,000
Operating Expenses 41,369,000 22,382,000 18,775,000 17,918,000 13,532,000
Operating Income -41,765,000 -22,490,000 -19,081,000 -17,854,000 -13,596,000
Interest Expense 0 904,000 33,000 32,000 -6,000
Income Before Tax -37,917,000 -22,370,000 -19,562,000 -18,208,000 -13,882,000
Income Tax Expense 0 -619,000 3,000 354,000 0
Net Income -37,917,000 -21,751,000 -19,562,000 -18,562,000 -13,882,000
Per Share
EPS -1.05 -2.68 -14.12 -38.62 -3.23
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 97,744,000 50,866,000 2,477,000 4,062,000
Short Term Investments 0 0 0 0
Net Receivables 33,000 229,000 0 3,000
Inventory 0 0 13,000 2
Total Current Assets 98,518,000 51,674,000 3,729,000 4,820,000
Property Plant Equipment 991,000 449,000 613,000 993,000
Goodwill and Intangibles 0 0 0 0
Total Assets 99,592,000 52,210,000 4,464,000 5,973,000
Liabilities
Account Payables 1,022,000 1,351,000 1,140,000 1,880,000
Short Term Debt 354,000 568,000 275,000 252,000
Total Current Liabilities 1,802,000 4,924,000 3,978,000 2,532,000
Long Term Debt 495,000 0 284,000 559,000
Total Liabilities 2,297,000 4,962,000 4,262,000 3,091,000
Shareholders Equity
Retained Earnings -228,176,000 -190,259,000 -167,889,000 -148,327,000
Total Shareholders Equity 97,295,000 47,248,000 202,000 2,882,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 97,744,000 50,866,000 2,477,000 4,062,000 19,769,000
Short Term Investments 0 0 0 0 0
Net Receivables 33,000 229,000 0 3,000 25,000
Inventory 0 0 13,000 2 0
Total Current Assets 98,518,000 51,674,000 3,729,000 4,820,000 20,608,000
Property Plant Equipment 991,000 449,000 613,000 993,000 577,000
Goodwill and Intangibles 0 0 0 0 0
Total Assets 99,592,000 52,210,000 4,464,000 5,973,000 21,379,000
Liabilities
Account Payables 1,022,000 1,351,000 1,140,000 1,880,000 274,000
Short Term Debt 354,000 568,000 275,000 252,000 213,000
Total Current Liabilities 1,802,000 4,924,000 3,978,000 2,532,000 1,369,000
Long Term Debt 495,000 0 284,000 559,000 0
Total Liabilities 2,297,000 4,962,000 4,262,000 3,091,000 1,369,000
Shareholders Equity
Retained Earnings -228,176,000 -190,259,000 -167,889,000 -148,327,000 -130,119,000
Total Shareholders Equity 97,295,000 47,248,000 202,000 2,882,000 20,010,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -37,917,000 -21,751,000 -19,562,000 -18,208,000
Depreciation & Amortization 396,000 343,000 381,000 392,000
Stock Based Compensation 17,426,000 830,000 452,000 870,000
Change in Working Capital -2,729,000 1,174,000 714,000 1,037,000
Operating Cash Flow -23,588,000 -19,403,000 -18,012,000 -15,899,000
Investing Activities
Capital Expenditure -18,000 -179,000 -1,000 -13,000
Investments -18,000 -179,000 -1,000 -13,000
Investing Cash Flow -18,000 -179,000 -1,000 -13,000
Financing Activities
Debt Repayment 0 0 0 0
Common Stock Issued/Repurchased 70,485,000 73,921,000 17,884,000 0
Dividends Paid 0 0 0 0
Financing Cash Flow 70,485,000 68,029,000 16,015,000 0
Summary
Free Cash Flow -23,606,000 -19,582,000 -18,013,000 -15,912,000
Net Change in Cash 46,928,000 48,439,000 -1,586,000 -15,708,000
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income -37,917,000 -21,751,000 -19,562,000 -18,208,000 -13,882,000
Depreciation & Amortization 396,000 343,000 381,000 392,000 424,000
Stock Based Compensation 17,426,000 830,000 452,000 870,000 634,000
Change in Working Capital -2,729,000 1,174,000 714,000 1,037,000 8,000
Operating Cash Flow -23,588,000 -19,403,000 -18,012,000 -15,899,000 -12,832,000
Investing Activities
Capital Expenditure -18,000 -179,000 -1,000 -13,000 -221,000
Investments -18,000 -179,000 -1,000 -13,000 -221,000
Investing Cash Flow -18,000 -179,000 -1,000 -13,000 -221,000
Financing Activities
Debt Repayment 0 0 0 0 0
Common Stock Issued/Repurchased 70,485,000 73,921,000 17,884,000 0 25,750,000
Dividends Paid 0 0 0 0 0
Financing Cash Flow 70,485,000 68,029,000 16,015,000 0 22,522,000
Summary
Free Cash Flow -23,606,000 -19,582,000 -18,013,000 -15,912,000 -13,053,000
Net Change in Cash 46,928,000 48,439,000 -1,586,000 -15,708,000 9,968,000